Interwest Venture Management Co
- SEC CIK
- 0001697720
- Latest filing
- Oct 20, 2023
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Oct 25, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 8
- 0 vs. Q2 2022
- Portfolio value
- $32.4M
- −$21.3M (−39.7%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 1,614,911 | $19.2M | 59.2% | 00.0% | Unchanged | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 560,990 | $4.22M | 13.0% | 00.0% | Unchanged | History |
| SERASera Prognostics, Inc. | CLASS A COM | 2,416,241 | $3.87M | 11.9% | 00.0% | Unchanged | History |
| REALTheRealReal, Inc. | COM | 2,354,080 | $3.53M | 10.9% | 00.0% | Unchanged | History |
| GKOSGLAUKOS Corp | COM | 16,347 | $870.0K | 2.7% | −334,897−95.3% | Reduced | History |
| AGTCApplied Genetic Technologies Corp | COM | 1,404,515 | $381.0K | 1.2% | 00.0% | Unchanged | History |
| VEROVenus Concept Inc. | COM | 658,657 | $290.0K | 0.9% | 00.0% | Unchanged | History |
| DAREDare Bioscience, Inc. | COM | 62,065 | $62.0K | 0.2% | 00.0% | Unchanged | History |